Press ReleasesSeptember 8, 2025β€’6 min read

Ursolic Acid Market expected to reach USD 6.452 billion by 2030

Key Highlights

Ursolic Acid Market Trends & Forecast According to a research study published by Knowledge Sourcing Intelligence (KSI), the ursolic acid market will expand from USD...

Ursolic Acid Market Trends & Forecast

According to a research study published by Knowledge Sourcing Intelligence (KSI), the ursolic acid market will expand from USD 4.785 billion in 2025 to USD 6.452 billion in 2030 at a CAGR of 6.16% during the forecast period.
The market is expected to grow, driven by the rise in global prevalence of non-communicable diseases such as obesity, diabetes, cardiovascular diseases, and cancer. The ursolic acid properties, which include decreasing fat buildup, offering antioxidant and anti-inflammatory, and enhancing muscle mass, while also improving the tolerance of glucose. These attributes of the ursolic acid make it a significant ingredient in diverse formulations in diverse sectors like pharmaceuticals, cosmetics, and nutraceuticals. Additionally, the growing focus on natural and biological ingredients is also promoting ursolic acid, as it is found in rosemary, apples, and basil, which makes it a natural and ideal alternative in pharmaceutical and other functional health supplements. The growth in anti-aging cosmetic formulation and food and beverages for functional health benefits aligns with healthy lifestyle advantages among consumers, which is also contributing to the growth of ursolic acid globally during the projected period.

Get In-Depth Analysis of the Ursolic Acid Market

This article covers the fundamentals. Our full market report provides the granular data, competitive landscape, and strategic insights you need to navigate the global ursolic acid industry.
  • ? Detailed Market Size & Growth Forecasts
  • ? Key Player Analysis & Market Share
  • ? Application Breakdowns & Regional Trends
A pie-chart showing Ursolic Acid Market Share By End-Use in 2025

Ursolic Acid Market Report Highlights

  • The powdered extract segment is estimated to attain a greater market share by 2030 in the form segment. The segment is growing due to its functionality of widespread application in pharmaceuticals, dietary supplements, and functional foods. Additionally, it is cost-effective, along with the ability to integrate with diverse formulations of products like capsules and powders, coupled with providing ease of dosing, which is predicted to boost the segment.
  • The 98% ursolic acid segment is the fastest-growing segment in the application of the global ursolic acid market, due to its specialized application in diverse sectors like healthcare and pharmaceuticals. Its high purity is effectively utilized in ultra-pure formulations, like in advanced research and development in cancer treatments and in premium cosmetic formulations. The segments are also promoted by the rising trend of organic and high-efficiency ingredients in the pharma and cosmetic industry.
  • The pharmaceutical industry is the dominating segment in the market in the end-use segment in the coming years. This is due to extensive ursolic acid usage in various therapeutic preparations. Further, the increased investment by diverse pharmaceutical companies in research and development for cancer medications has led to advancements in treatment for diverse other health concerns like diabetes and cardiovascular disease. This is due to properties of ursolic acid, which support these developments, and their being natural also increases their preference for the preparation of organic drugs.
  • North America held the largest global ursolic acid market share on account of the robust healthcare industry with the presence of advanced healthcare infrastructure in the region, especially, United States. Moreover, the increased health awareness among consumers is promoting the demand for natural health supplements. The prevalence of lifestyle diseases like diabetes is promoting the research and development investment across the region, in turn propelling the market.

Explore the Nutraceuticals Market

Ursolic acid is a key ingredient in nutraceuticals. Get our in-depth report on the Nutraceuticals Market to understand global trends, key applications, and growth forecasts.

Report Coverage:

Report Metric Details
Ursolic Acid Market Size in 2025 US$4.785 billion
Ursolic Acid Market Size in 2030 US$6.452 billion
Growth Rate CAGR of 6.16%
Drivers 2020 to 2030
Restraints 2020 to 2023
Segmentation
  • Form
  • Product Type
  • End-Use
  • Geography
Geographical Segmentation North America, South America, Europe, Middle East and Africa, Asia Pacific
List of Major Companies in Ursolic Acid Market
  • Changsha E.K HERB
  • Hunan NutraMax
  • Cayman Chemical
  • Tokyo Chemical Industry Pvt. Ltd.
  • Sigma-Aldrich
Customization Scope Free report customization with purchase

Ursolic Acid Market Growth Drivers and Restraints

Growth Drivers:
  • Growing Prevalence of Chronic and Lifestyle Diseases: The rise in chronic disorders such as cancer, obesity, diabetes, and cardiovascular diseases, which are estimated to cause about 74 percent of all types of deaths globally. This is a major driver due to ursolic acid properties in being anticancer and antiviral, along with working in improving glucose tolerance and diverse additional abilities, which makes it a preferable ingredient in pharmaceuticals.
  • Increasing Preference towards Natural and Plant-Derived Products: The growing awareness among consumers about the side effects of synthetic drugs is leading to a shift in demand towards natural and plant-based ingredients like ursolic acid. This is promoted with a rise in demand for biobased functional supplements and anti-aging cosmetics.
Restraints:
  • Potential Health Risks from Excessive Consumption: The concern of the overuse of ursolic acid is linked with health risks such as abdominal swelling, DNA damage, skin rashes, or blood in urine are adverse effects that are increasingly risky for cardiovascular patients.
  • High Cost of Extraction and Production: The complex process involved in the extraction and purification of ursolic acid from natural sources like plants is intensive and costly, which could limit its scalability and increase the end product cost.

Ursolic Acid Market Key Development

  • Collaboration: In January 2025, Virbac announced the launch of a new pet supplement which is URSOLYX Soft Chews, which was designed in collaboration with Emmyon Inc. The key component for this was ursolic acid, which targets skeletal muscle mRNA expressions that assist in reverse markers of muscle atrophy.

Ursolic Acid Market Segmentation

Knowledge Sourcing Intelligence has segmented the global ursolic acid market based on form, product type, end-use, and region: Ursolic Acid Market, By Form
  • Liquid Extract
  • Powdered Extract
Ursolic Acid Market, By Product Type
  • 25% Ursolic Acid
  • 50% Ursolic Acid
  • 90% Ursolic Acid
  • 98% Ursolic Acid
Ursolic Acid Market, By End-Use
  • Pharmaceuticals
  • Food and Beverage
  • Cosmetics
  • Nutraceuticals
  • Others
Ursolic Acid Market, By Region
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Others
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • South Korea
    • Others

Ursolic Acid Market Key Players

  • Sami-Sabinsa group
  • Changsha Staherb Natural Ingredients
  • Run Shaanxi Days of Bio-tech
  • Shaanxi Huike Botanical Development
  • Changsha Luyuan Bio-Tech
  • Changsha E.K. HERB
  • Hunan NutraMax
  • Cayman Chemical
  • Tokyo Chemical Industry Pvt. Ltd.
  • Sigma-Aldrich

Go from Insight to Action with Our Market Research

You've seen the overview. Now, get the detailed data and strategic analysis you need to stay ahead in the health and wellness market. Explore our related, in-depth reports. Each report includes comprehensive data, forecasts, and competitive analysis to empower your business decisions.

Have questions?

More Press Releases

Aug 5, 2026

Lifestyle-Associated Cancer Epidemiology Market is expected to reach USD 13.12 billion by 2031

The worldwide market for lifestyle-associated cancer epidemiology is expected to expand rapidly, owing to the rising global awareness of modifiable risk factors such as tobacco use, obesity, poor diet, alcohol consumption, and physical inactivity, which together contribute significantly to cancer incidence. Health organizations, along with research institutions, are investing in enhanced surveillance, behavioral risk monitoring, cancer registries, and prevention strategies to address the growing burden of preventable cancers. In recent years, the World Health Organization and several national bodies have emphasized data-driven epidemiology. These initiatives support targeted interventions, policy measures, and screening programs. Additionally, the widespread adoption of digital epidemiology tools, precision prevention approaches, and AI-powered analytics is fueling the demand for robust epidemiology infrastructure worldwide.

Click here to read→
Jul 30, 2026

Psycho-Oncology Digital Health Market is anticipated to surpass USD 290.01 million in 2031 at a CAGR of 8.5%

The psycho-oncology digital health market is expanding as healthcare providers increasingly integrate digital mental health solutions into cancer care. Growing demand for AI-driven platforms, digital cognitive behavioral therapy, telehealth, and mobile applications is improving access to psychological support. North America leads the market, while Asia Pacific is expected to witness the fastest growth.

Click here to read→
Jul 24, 2026

Intratumoral Injection Therapy Market is expected to reach USD 630.39 million by 2031

The worldwide market for Intratumoral Injection Therapy is expected to experience substantial growth in the market due to the increasing demand for localized cancer treatments that are essential in enhancing therapeutic efficacy while also minimizing systemic toxicity. Intramural injection therapy is often involved with direct administration of therapeutic agents into tumors, which enables high local drug concentrations and targets immune activation. Growing interest in gene therapies, cancer immunotherapy, and on-politic viruses, including cytokine-based therapies are also accelerating market expansion.

Click here to read→